Ledger.Open graph →
SEC Form D · Amendment · filed December 22, 2009

NGM BIOPHARMACEUTICALS INC

Offering
$26.6M
Sold
$26.6M
Exemption
—
Industry
Biotechnology
Location
HILLSBOROUGH, CA
Type
—

People & firms on this filing (16)

Michael Hormaechea · Boise, IDExec · DirectorJames J. Lynch · HARTFORD, CTExec · DirectorHelen Kim · South San Francisco, CAExecGail Naughton · Encinitas, CADirectorMarc Leschly · Palo Alto, CADirectorPeter Svennilson · Gulf Stream, FLDirectorArthur D. Levinson · South San Francisco, CADirectorLuis Bayol · South San Francisco, CAExecSteven J. Kapiloff · HARTFORD, CTDirectorMonika Wingate · Madison, WIExec · DirectorJane Boutelle · Madison, WIExec · DirectorKyle Cummings · Sisters, ORExecRobert Pinnick · Bend, ORExecRajan Sobhani · Plano, TXDirectorRavi Mohan · Menlo Park, CADirectorFrank G. Mazzola · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗